Back
Xcel Energy 10K Form
Sell
50
XEL
Xcel Energy
Last Price:
62.70
Seasonality Move:
2.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | XEL/Xcel Energy Quarterly |
| 2024-02-21 | 10K | XEL/Xcel Energy Annual |
| 2023-10-27 | 10Q | XEL/Xcel Energy Quarterly |
| 2023-07-27 | 10Q | XEL/Xcel Energy Quarterly |
| 2023-04-27 | 10Q | XEL/Xcel Energy Quarterly |
| 2023-02-23 | 10K | XEL/Xcel Energy Annual |
Receive XEL News And Ratings
See the #1 stock for the next 7 days that we like better than XEL
XEL Financial Statistics
Sales & Book Value
| Annual Sales: | $14.21B |
|---|---|
| Cash Flow: | $-641M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $32.21 |
| Price / Book: | 1.97 |
Profitability
| EPS (TTM): | 3.35000 |
|---|---|
| Net Income (TTM): | $1.86B |
| Gross Margin: | $5.98B |
| Return on Equity: | 10.58% |
| Return on Assets: | 2.88% |
Xcel Energy Earnings Forecast
Key Xcel Energy Financial Ratios
- The Gross Profit Margin over the past 30 years for XEL is 42.09%.
- The Selling, General & Administrative Expenses for XEL have been equal to 0.00% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 56.69% of Operating Income.
- The Net Earning history of XEL is 12.47% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 27 years.
Xcel Energy Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Electric Utilities |
| Sector: | Utilities |
| Current Symbol: | XEL |
| CUSIP: | 98389B |
| Website: | xcelenergy.com |
Debt
| Debt-to-Equity Ratio: | 1.64 |
|---|---|
| Current Ratio: | 0.97 |
| Quick Ratio: | 0.61 |
Price-to-Earnings
| Trailing P/E Ratio: | 19.74 |
|---|---|
| Forward P/E Ratio: | 16.54 |
XEL Technical Analysis vs Fundamental Analysis
Sell
50
Xcel Energy (XEL)
is a Sell
Is Xcel Energy a Buy or a Sell?
-
Xcel Energy stock is rated a Sell
The current Xcel Energy [XEL] share price is $63.36. The Score for XEL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.